ReviewThe cardioprotection of calcitonin gene-related peptide-mediated preconditioning
Introduction
Since the term ischemic preconditioning was originally recognized by Murry et al. (1986), considerable progress has been made in understanding this phenomenon. Ischemic preconditioning shows two phases: an early phase of protection termed “classic preconditioning”, which occurs within minutes and disappears within 2 to 4 h. Subsequently, a delayed phase of protection termed “second window of protection” appears 24 h after initial ischemic preconditioning and lasts for 48 to 72 h. Preconditioning of the heart has been exploited from ischemic stimulus to heat stress and some drugs Pagliaro et al., 2001, Bolli, 2000.
The mechanisms underlying preconditioning have not yet been elucidated but one suggestion is that the protective effect is mediated by endogenous active substances, including neurotransmitters and autocoids (Parratt, 1994). We and others have shown that endogenous calcitonin gene-related peptide (CGRP) plays an important role in mediation of preconditioning (Li et al., 2000).
Section snippets
The biology characteristic of CGRP
CGRP is a major transmitter in capsaicin-sensitive sensory nerves and has two isoforms named CGRPα and CGRPβ. CGRPα was cloned in the early 1980s from the gene encoding calcitonin (Amara et al., 1982). In the thyroid, calcitonin is the main product of this gene, whereas, in neural tissues, a novel neuropeptide, CGRPα, is generated. A second CGRP homologue, CGRPβ, was later characterized, bearing high sequence homologies with the α-form but that was not derived from the calcitonin gene (Amara et
CGRP and ischemic preconditioning
The release of CGRP is regulated by multiple factors, such as transient ischemia, hyperthermia or autocoids, and the elevated level of CGRP during ischemia probably constitutes a compensatory response Kallner, 1998, Franco-Cereceda, 1988, Kress and Zeilhofer, 1999. Administration of exogenous CGRP has been shown to alleviate the incidence of reperfusion-induced ventricular arrhythmia and to protect the cultured myocyte against hypoxygen injury Zhang et al., 1994, Ren et al., 1993. It has been
CGRP and heat stress-induced cardioprotection
It has been documented that sublethal hyperthermia is also capable of inducing preconditioning-like protection, including classical or early preconditioning and delayed preconditioning or “second window” protection Gowda et al., 1998, Yamashita et al., 1998. The mechanism responsible for the beneficial effect of heat stress is still not fully understood. Early studies have found that a stress, cold or heat, is also capable of activating capsaicin-sensitive sensory nerves and stimulating the
CGRP and pharmacological preconditioning
Substitution of some drugs for ischemic stimulus is also capable of inducing a protection similar to that with ischemic preconditioning and this is described as pharmacological preconditioning. The protective effects of some drug-induced preconditioning have been suggested to be related to stimulation of endogenous active substances. For example, angiotensin-converting enzyme inhibitors or monophospheryl lipid A-induced preconditioning protects the myocardium against damages due to
Mechanisms of CGRP-mediated cardioprotection
The exact mechanisms responsible for the protective effects of CGRP remain unclear. Endogenous mediators including neurotransmitters bind to specific receptors and then activate the endogenous protective mechanisms via complex signal pathways, which are related to the activation of protein kinase C or ATP-sensitive K+ (KATP) channels. There is evidence to suggest that CGRP enhances the activity of protein kinase C and activates KATP channels in vascular smooth muscle Bell et al., 1995, Wellman
Summary
The results from animal experiments and clinical studies have shown that CGRP plays an important role in the mediation of ischemic preconditioning. Endogenous CGRP is also involved in mediation of the preconditioning of the heart induced by heat stress or some drugs. It is likely that CGRP-mediated early preconditioning only involves the release of CGRP, while the development of CGRP-mediated delayed preconditioning is related to the upregulation of α- but not β-CGRP gene expression via NO
References (60)
- et al.
Protein A cDNA encoding the calcitonin gene-related peptide type 1 receptor
J. Biol. Chem.
(1996) - et al.
The calcitonin-like sequence of the beta CGRP gene
FEBS Lett.
(1986) - et al.
Hypertrophic effects of calcitonin gene-related peptide (CGRP) and amylin on adult mammalian ventricular cardiomyocytes
J. Mol. Cell. Cardiol.
(1995) - et al.
Expression of alpha-calcitonin gene-related peptide in the enteric nervous system of rat small intestine
Neurosci. Lett.
(2000) - et al.
Protective effects of nitroglycerin-induced preconditioning mediated by calcitonin gene-related peptide in rat small intestine
Eur. J. Pharmacol.
(2001) - et al.
Antagonistic effect of human alpha-CGRP [8–37] on the in vivo regional haemodynamic actions of human alpha-CGRP
Biochem. Biophys. Res. Commun.
(1990) - et al.
Cardioprotection by local heating: improved myocardial salvage after ischemia and reperfusion
Ann. Thorac. Surg.
(1998) - et al.
Monophosphoryl lipid A-induced delayed preconditioning is mediated by calcitonin gene-related peptide
Eur. J. Pharmacol.
(2001) - et al.
Effects of substance P and calcitonin gene-related peptide on axonal transport in isolated and cultured adult mouse dorsal root ganglion neurons
Brain Res.
(2000) - et al.
The cardioprotective effects of nitroglycerin-induced preconditioning are mediated by calcitonin gene-related peptide
Eur. J. Pharmacol.
(1999)
Myocardial outflow of calcitonin gene-related peptide in relation to metabolic stress during coronary artery bypass grafting without cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg.
Capsaicin, protons and heat: new excitement about nociceptors
Trends Pharmacol. Sci.
Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction
Am. Heart J.
Calcitonin gene-related peptide-induced preconditioning protects against ischemia–reperfusion injury in isolated rat hearts
Eur. J. Pharmacol.
Cardiac ischemic preconditioning improves lung preservation in valve replacement operations
Ann. Thorac. Surg.
Calcitonin gene-related peptide-induced preconditioning improves preservation with cardioplegia
Ann. Thorac. Surg.
Evidence for calcitonin gene-related peptide-mediated ischemic preconditioning in the rat heart
Regul. Pept.
Ischemic preconditioning: from the first to the second window of protection
Life Sci.
Ischemic preconditioning, the most effective gastroprotective intervention: involvement of prostaglandins, nitric oxide, adenosine and sensory nerves
Eur. J. Pharmacol.
Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitation
Trends Pharmacol. Sci.
Inhibition of cardiac tumor necrosis factor-alpha production by calcitonin gene-related peptide-mediated ischemic preconditioning in isolated rat hearts
Eur. J. Pharmacol.
Involvement of α-calcitonin gene-related peptide in monophosphoryl lipid A-induced delayed preconditioning in rat hearts
Eur. J. Pharmacol.
The heme oxygenase-1 pathway is involved in calcitonin gene-related peptide-mediated delayed cardioprotection induced by monophosphoryl lipid A in rats
Regul. Pept.
Induction of alpha-calcitonin gene-related peptide mRNA expression in rat dorsal root ganglia by heat stress involves the heme oxygenase-1/carbon monoxide pathway
Neuropeptides
Improvement of preservation with cardioplegia induced by heat stress is mediated by calcitonin gene-related peptide
Regul. Pept.
Quantitative analysis of cutaneous calcitonin gene-related peptide content in response to acute cutaneous mechanical or thermal stimuli and immobilization-induced stress in rats
Neuropeptides
Pivotal role of nitric oxide in delayed pharmacological preconditioning against myocardial infarction
Toxicology
Delayed cardioprotection by intestinal preconditioning is mediated by calcitonin gene-related peptide
Eur. J. Pharmacol.
Preconditioning of swine heart with monophosphoryl lipid A improves myocardial preservation
Ann. Thorac. Surg.
Role of inducible nitric oxide synthase in pharmacological “preconditioning” with monophosphoryl lipid A
J. Mol. Cell Cardiol.
Cited by (86)
Roles of calcitonin gene-related peptide in the skin, and other physiological and pathophysiological functions
2021, Brain, Behavior, and Immunity - HealthThe neurobiology of cluster headache
2021, Handbook of Clinical NeurologyRole of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology
2020, Pharmacological ResearchAnti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis
2019, PeptidesCitation Excerpt :Overall, these findings in animal models suggest the need of monitoring hard end-points of CV risk –rather than just BP- in the clinical trials with anti-CGRP mABs. In animal models of ischemic disorders of the CV system, CGRP appears to be an important mediator of delayed preconditioning, the latter meaning that the severity of damage caused by ischemic events can be reduced by the pre-exposure to a preconditioning agent [38]. However, the relevance of CGRP in delayed preconditioning in the clinical setting remains to be fully established.
Rutaecarpine: A promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu)
2019, Pharmacological Research